Ozempic

Eli Lilly is seeking FDA approval for tirzepatide for chronic weight management. The drug could be approved by the end of the year.

Eli Lilly releases more data for new obesity drug, moving toward fast-track approval

Allison Aubrey

There's already a huge demand for existing weight-loss drugs, so the new medication is highly anticipated. Obesity affects an estimated 650 million adults globally.

Health News Florida

Social media fuels enthusiasm for new weight-loss drugs. Are regulators watching?

Darius Tahir - KFF Health News

Online platforms are overflowing with testimonials for GLP-1s. The drugs show promise for inducing weight loss, but many aren’t FDA-approved for that use.

ShantaQuilette Develle Carter-Williams, 44, was prescribed Ozempic after a stroke put her life in danger. The drug worked wonders — until she couldn't get it.

NPR Health

'You forget to eat': How Ozempic went from diabetes medicine to blockbuster diet drug

Stacey Vanek Smith

The Novo Nordisk diabetes medication was found to cause significant weight loss in users and has since become a blockbuster drug and very big business.

Wegovy has been called "a major breakthrough" given how well it works to reduce body weight. But the injection drug is extremely expensive and when people can't afford to stay on it, they experience rebound weight gain that's hard to stop.

NPR Health

Wegovy works. But here's what happens if you can't afford to keep taking the drug

Allison Aubrey

The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.